L-Ergothioneine for Liver & Metabolic Wellness Research
Health-conscious people usually get regular checkups. But when the results come back, you may find that more than one marker is borderline or elevated — liver enzymes, blood lipids, and uric acid all trending in the wrong direction at the same time.
Why do these problems show up together? And is there a way to support your overall metabolic health rather than chasing each number separately?
GeneIII's research found that L-Ergothioneine not only improved liver function markers, but also produced simultaneous positive changes across:
- Blood lipids — both "bad" cholesterol down and "good" cholesterol up
- Inflammation — key inflammatory signals reduced by over 60%
- Oxidative stress — damage markers cut in half, protective enzymes nearly tripled
This article walks you through what is behind those multiple elevated markers, and what GeneIII's research has shown about L-Ergothioneine's role in metabolic wellness.
Why These Problems Tend to Show Up Together
Late nights, sitting all day, drinking, rich food, chronic stress — these everyday habits quietly pile pressure onto your metabolic system over time.
Your liver processes everything you eat and drink. Your kidneys filter roughly 180 liters of blood per day. They are the hardest-working organs in your body, and the first to feel the strain.
When this cumulative load exceeds your body's ability to keep up, it does not show up in just one place:
- Liver markers creep up
- Blood lipids start drifting
- Uric acid edges higher
All at once. These are not coincidences — they are the same underlying pressure expressing itself across different organs.
This also explains why addressing each marker individually often has limited results. The overall metabolic environment is what is under strain.
In GeneIII's Research, the Improvements Went Far Beyond the Liver
GeneIII conducted a systematic liver study (bioRxiv preprint, DOI: 10.64898/2026.02.14.705887) using L-Ergothioneine at 99.99% purity (third-party HPLC verified).
The results showed improvements well beyond liver function alone.
Blood lipids moved in the right direction across the board:
- Triglycerides decreased 40.6%
- Total cholesterol decreased 40.4%
- LDL ("bad cholesterol") decreased 22.9%
- HDL ("good cholesterol") increased 35%
The pattern is clear: what should go down went down, what should go up went up.
Internal inflammatory signals were significantly reduced:
- IL-6 decreased 60.5%
- IL-1β decreased 67.1%
When these two markers stay elevated over time, what you may actually feel is persistent fatigue, poor sleep, and difficulty managing weight. They quietly affect your daily quality of life without showing obvious symptoms.
Oxidative damage decreased while the body's own defenses strengthened:
- MDA (a measure of oxidative damage) decreased 50.2%
- GSH-Px (the body's own antioxidant enzyme) increased 198.2%
For those with social drinking occasions, an additional finding worth noting:
Alcohol clearance efficiency improved by 54.4%, significantly outperforming the Silybin control group. This suggests L-Ergothioneine may help the liver process alcohol-related burden more efficiently.
What Participants Noticed First in the Human Trial
GeneIII's liver health human trial (ChiCTR2400093739) enrolled participants taking 60mg of GeneIII L-Ergothioneine daily for 30 days.
The capsules used in the trial have received an FDA "No Questions" Letter for GRAS status (GRN 001270) and are manufactured under cGMP pharmaceutical-grade standards. No adverse events were recorded throughout the study.
Lab markers improved — ALT, AST, and GGT all decreased significantly.
But what most participants noticed first was not their lab report. It was how they felt:
- Daytime Energy: More than half reported improved daytime function (daytime dysfunction scores decreased 51%)
- Energy: Nearly 40% felt their daily energy and physical capacity improving (physical function improved 39%)
The numbers on the lab report were getting better, and the way people felt was getting better too — both happening at the same time.
Why One Ingredient Can Help Across Multiple Areas
Your cells carry a transporter protein called OCTN1, which is specifically designed to receive L-Ergothioneine.
This protein is distributed across multiple organs:
- Liver — your metabolic processing center
- Kidneys — your filtration system
- Brain — your highest oxygen-consuming organ
- Heart — under constant oxidative demand
After oral intake, your body routes L-Ergothioneine to wherever the metabolic pressure is highest, based on each organ's real-time needs.
You do not need separate supplements for your liver, your lipids, and your inflammation — your body already knows where to send it.
GeneIII controls the full production chain from strain engineering through fermentation, purification, and commercial-scale manufacturing — backed by 33 patents.
This end-to-end control ensures that purity and potency stay consistent across every batch, which matters especially for long-term supplementation.
GeneIII Is Expanding Its Research Across More Health Areas
The liver and metabolic data established a foundation, but GeneIII has not stopped there.
GeneIII currently has 8 registered L-Ergothioneine human clinical trials on the Chinese Clinical Trial Registry, covering:
- Liver health
- Menstrual pain
- Ovarian health
- Postpartum recovery
- Cognitive function
- Kidney health
- Sperm health
In the United States, 539 licensed clinicians have awarded GeneIII L-Ergothioneine the Clinicians' Choice designation on Front Row MD.
All trial information is publicly verifiable at chictr.org.cn.
Daily Supplementation
Two capsules per day (60mg) matches the protocol used in the liver health human trial.
Take with breakfast — simple to incorporate into your existing routine.
Each GeneIII capsule contains 30mg of L-Ergothioneine in an HPMC plant-based shell, free from dairy, shellfish, peanuts, artificial sweeteners, and artificial preservatives. Compatible with fish oil, vitamin D, probiotics, and other common daily supplements.
FAQ About L-Ergothioneine and Metabolic Health
Q1: How long before I notice changes?
GeneIII's human trial showed significant improvements in liver markers, sleep, and physical function at 30 days. For lab-based metabolic markers, consider retesting after 2–3 months of consistent supplementation to compare.
Q2: I am taking prescription medication. Can I take this too?
L-Ergothioneine absorbs through the dedicated OCTN1 channel, which is distinct from most common supplement pathways. If you are on prescription medications such as statins or blood pressure drugs, consulting your doctor first is recommended.
Q3: Why can one ingredient help both liver function and blood lipids?
Liver dysfunction and abnormal blood lipids are often different expressions of the same metabolic strain. When L-Ergothioneine is delivered to the liver via OCTN1 and liver function improves, the lipid metabolism closely tied to liver health tends to improve along with it.
Q4: Is it safe for long-term use?
GeneIII's L-Ergothioneine has received an FDA "No Questions" Letter for GRAS status (GRN 001270). No adverse events were recorded in the 30-day human trial, and the preclinical exercise study at higher doses over 4 weeks also reported no adverse effects.
References & Trial Information
All trial information verifiable at chictr.org.cn.
Note: Human trial data referenced in this article comes from open-label study designs. Larger randomized controlled trials are warranted. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
